According to Janice Jin Hwang, clinician and endocrinologist at the University of North Carolina at Chapel Hill, these legitimate pharmacies have very good quality-control standards. The FDAs compounding program aims to protect patients from poor quality compounded drugs, while preserving access to lawfully marketed compounded drugs. Earlier in 2025, the FDA released an import alert blocking potentially unsafe APIsmanufactured for the production of GLP-1 drugsfrom entering the U.S
This is neurochemistry, and it responds to intervention
it materially affected the US compounded peptide market
Confused about GLP-1s
If it isnt appropriate, they wont prescribe it
Sun Y, Shu Y, Liu B, Liu P, Wu C, Zheng R, et al